Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial

Abstract Background Mineralocorticoid receptor antagonists (MRAs) are often underutilized in patients with heart failure (HF), particularly those with diabetes and/or chronic kidney disease (CKD). However, the impact of concurrent diabetes and CKD on the efficacy and safety of eplerenone in acute HF...

Descrición completa

Detalles Bibliográficos

Principais autores:	Masatake Kobayashi, Akira Yamashina, Kazuhiro Satomi, Masataka Watanabe, Ryu Takagi, Ayako Tezuka, Shin Ito, Masanori Asakura, Masafumi Kitakaze
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2025-03-01
Series:	Cardiovascular Diabetology
Assuntos:	Acute heart failure Eplerenone Mineralocorticoid receptor antagonist Diabetes Chronic kidney disease Prognosis
Acceso en liña:	https://doi.org/10.1186/s12933-025-02659-y
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!